Analysis of Risk Factors for the Recurrence of Helicobacter Pylori Infection in Baoding Children Aged 4 - 16 Years

authors:

avatar Yongnan Teng 1 , 2 , avatar Qingwei Dong 1 , 2 , avatar Xiao Liu 1 , 2 , avatar Naying Zuo 1 , 2 , avatar Yuanda Zhang ORCID 3 , *

Department of Gastroenterology, Beijing Children's Hospital Affiliated to Capital Medical University Baoding Hospital, Baoding, Hebei, China
Key Laborary of Clinical Research on Respiratory Digestive Disease, Hebei Baoding, China
Department of Nutriology, Beijing Children's Hospital Affiliated to Capital Medical University Baoding Hospital, Baoding, Hebei, China

how to cite: Teng Y , Dong Q, Liu X, Zuo N, Zhang Y . Analysis of Risk Factors for the Recurrence of Helicobacter Pylori Infection in Baoding Children Aged 4 - 16 Years. Iran J Pediatr. 2024;34(3):e139752. https://doi.org/10.5812/ijp-139752.

Abstract

Background:

Helicobacter pylori infection affects over 50% of the world's population and is the primary cause of duodenal and gastric ulcers, as well as gastric cancer.

Objectives:

To investigate the risk factors for recurrence following successful eradication of H. pylori infection in children aged 4 - 16 years in the Baoding area.

Methods:

The study included 328 children diagnosed with H. pylori infection at our hospital from January 2021 to June 2022, who had successfully undergone eradication treatment. A questionnaire covering personal history, family history, health status, and family socioeconomic status was administered to the children, coupled with a 1-year follow-up. Recurrence within this period was monitored, along with an analysis of the risk factors for recurrence post-eradication.

Results:

Out of 328 children with H. pylori infection, 295 (89.9%) were successfully followed up. Among these, 55 (18.6%) tested positive on the 13C-urea breath test and were considered to have recurrent infection (recurrence group), while 240 (81.4%) tested negative and were considered to have no recurrence (non-recurrence group). Univariate chi-square analysis of the questionnaire results indicated that age (P < 0.05), number of eradication treatments (P < 0.05), mother's education level (P < 0.05), place of residence (P < 0.05), family income (P < 0.05), family history of H. pylori infection (P < 0.05), separate meals (P < 0.05), and lunch location (P < 0.05) significantly influenced H. pylori recurrence. Multivariate analysis, which included factors showing significant differences in univariate analysis, was performed using a logistic regression model. This analysis identified multiple treatments (> 2 eradication attempts), residing in rural areas, and low family income as combined risk factors for H. pylori recurrence in children. Conversely, being older than 10 years, eating separate meals, and higher maternal education level emerged as protective factors against recurrence.

Conclusions:

There is a relatively high rate of H. pylori recurrence among children aged 4 - 16 years in this region, which may be linked to age, number of eradication treatments, dietary and hygiene habits, educational levels of family members, and economic status.

1. Background

Helicobacter pylori infection affects more than 50% of the world's population and is the primary cause of duodenal and gastric ulcers, as well as gastric cancer (1). Children are particularly susceptible to H. pylori infection (2), with approximately one-third of children worldwide being infected (3). Moreover, about two-thirds of adult patients acquired their H. pylori infection before the age of 10 (4, 5), underscoring the importance of controlling H. pylori infection during childhood. Currently, "triple therapy" is commonly used clinically to eradicate H. pylori infection (6). However, some patients may experience a recurrence of the infection after receiving treatment, which represents a significant challenge in the management of H. pylori infection (7). Recurrence rates are notably higher among younger patients.

2. Objectives

Given the context, our research team aims to understand the recurrence of H. pylori infection in children in the local region and the risk factors associated with its recurrence. We utilized a standardized survey questionnaire to gather data on personal history (e.g., prior infections, history of treatment, history of drug allergy, etc.), family history (e.g., family history of H. pylori infection, gastric and duodenal ulcers, gastrointestinal malignancies, etc.), health status, and family socioeconomic status (e.g., family economic income, education level and occupation of the parents, etc.). This was followed by a 1-year follow-up of children in the local region who had successfully undergone eradication therapy. The findings are reported below.

3. Methods

3.1. General Information

This study is a retrospective clinical investigation. The sample size was calculated based on the eradication rate of H. pylori in China, which ranges from 70% to 85%. The sample size formula used for counting data (rate) is n = z2 × p × (1 - p) / d2, employing a 95% confidence interval where z = 1.96, p = 77.5%, and the acceptable margin of error (d) = 0.05. The minimum sample size calculated was 268 individuals. Due to potential data incompleteness and other factors, the final sample comprised 328 participants.

The study subjects were 328 children aged 4 - 16 years, diagnosed with H. pylori infection and successfully treated in a hospital from January 2020 to June 2021. Among the enrolled children, there were 177 boys and 151 girls, with an average age of 8.9 ± 2.8 years. The children were assessed through a questionnaire survey covering personal history, family history, health status, and family socioeconomic status, followed by a 1-year follow-up. The study received approval from the Institutional Ethics Committee of the Hospital, and written informed consent was obtained from all participants.

Diagnostic criteria for H. pylori infection included children exhibiting positive results from any of the following tests: rapid urease test, endoscopic pathological staining, or the 13C-urea breath test, conducted due to digestive system symptoms or a strong demand for an H. pylori test (8).

3.2. Inclusion Criteria

(1) Children aged 4 - 16 years;

(2) Positive 13C-urea breath test, gastric mucosal rapid urease test, or tissue section staining, followed by a negative 13C-urea breath test after 4 weeks of eradication treatment;

(3) Children capable of completing a 1-year follow-up and returning to the hospital every 6 months for a repeat 13C-urea breath test.

3.3. Exclusion Criteria

(1) Children with major organ or mental diseases;

(2) Children with poor compliance who cannot complete follow-up on time;

(3) Children who had an acute infectious disease in the past month.

3.4. Research and Investigation Methods

Our unified survey questionnaire was based on the national H. pylori infection research questionnaire, adapted to reflect local economic levels and dietary habits. The questionnaire covered various topics, including sociodemographic characteristics (gender, age, parental education level, income status, etc.), dietary habits (shared meals, meal structure, etc.), lifestyle (living in rural or urban areas, cohabitation with parents, campus residency, etc.), and H. pylori-related diseases (treatment history, treatment plans, frequency, and presence of digestive tract diseases). All enrolled children were surveyed on personal history, family history, health status, and family socioeconomic status by medical staff with intermediate or higher professional titles and systematic training. The authenticity and reliability of the questionnaire were maintained during the survey, with care taken to avoid leading questions. Additionally, the 13C-urea breath test was re-administered at 6 and 12 months post-enrollment. Children testing positive on these subsequent tests were considered to have a recurrence of H. pylori infection. The study process flowchart is shown in Figure 1.

The flowchart of study process
The flowchart of study process

3.5. Statistical Analysis

Statistical analysis was conducted using SPSS 25.0 software. Enumerated data were expressed as n(%), and measurement data were presented as means (± standard deviation). The chi-square test was used for inter-group comparisons of categorical data, such as gender and recurrence rate, while the t-test was used for inter-group comparisons of continuous data, such as age. The results of the questionnaire survey were statistically analyzed using a binary logistic regression equation, with the recurrence rate as the dependent variable. A P-value of < 0.05 was considered statistically significant.

4. Results

Out of the 328 children enrolled with H. pylori infection, 295 (89.9%) were successfully followed up, while 33 cases were lost to follow-up, resulting in a loss rate of 10.1%. Among the children who were successfully followed up, 55 (18.6%) tested positive on the 13C-urea breath test and were considered as having a recurrence (the recurrence group), while 240 (81.4%) tested negative and were considered as not having a recurrence (non-recurrence group). The recurrence group comprised 31 boys and 24 girls, while the non-recurrence group included 132 boys and 108 girls, with average ages of 8.3 ± 2.1 years and 9.0 ± 2.8 years, respectively. No statistically significant differences were found in the comparison of gender and age between the two groups (P > 0.05), as presented in Table 1.

Table 1.

Comparison of General Data between the Recurrence Group and the Non-recurrence Group

GroupsCasesNumber of BoysAge, y
Recurrence group55318.3 ± 2.2
Non-recurrence group2401329.0 ± 2.8
χ2/t value0.0341.652
P-value> 0.05 a> 0.05 b

A questionnaire survey was conducted on the personal history, family history, health status, and family socioeconomic status of the enrolled children. Univariate chi-square analysis of the questionnaire results indicated that age (χ2 = 4.122, P = 0.042), number of eradication treatments (χ2 = 12.761, P < 0.001), the mother's education level (χ2 = 17.166, P < 0.001), place of residence (χ2 = 5.252, P = 0.022), family income (χ2 = 9.103, P = 0.003), and whether meals were separate (χ2 = 13.241, P < 0.001) were significant factors influencing H. pylori infection recurrence (Table 2).

Table 2.

Univariate Analysis of Personal History, Family History, Health Status, Family Socioeconomic Status for the Recurrence of H. pylori Infection in Children

Factors Related to H. pylori Infection RecurrenceRegression CoefficientStandard Errorχ2P-ValueOR95%CI
Age-0.8330.4104.1220.0420.4350.195 - 0.972
Times of eradication treatment1.3390.37512.761< 0.0013.8161.830 - 7.956
Place of residence0.8640.3775.2520.0222.3721.133 - 4.967
Family economic income1.1400.3789.1030.0033.1281.491 - 6.562
H. pylori infection in the family members or not0.6700.3863.0070.0831.9530.916 - 4.163
Separate meals or not-1.4360.39513.241< 0.0010.2380.110 - 0.516
Education degree of the mother-1.6440.39717.166< 0.0010.1930.089 - 0.420
Lunch place-0.6700.39616.1260.0910.5120.235 - 1.113

Further multivariate analysis included these significant factors from the univariate analysis in a logistic regression model. The results (Table 3) revealed that undergoing fewer than two eradication treatments, living in a city, and having a high family income were combined protective factors against H. pylori infection recurrence in children (OR < 1, P < 0.05). Conversely, being younger than 10 years old, not having separate meals, and having a mother with a lower education level were combined risk factors for H. pylori infection recurrence in children (OR > 1, P < 0.05).

Table 3.

Multivariate Analysis of Personal History, Family History, Health Status, Family Socioeconomic Status for the Recurrence of H. pylori Infection in Children

Factors Related to H. pylori Infection RecurrenceRegression CoefficientStandard Errorχ2P-ValueOR95%CI
Age of < 10 years old0.8880.4054.8100.0282.4311.099 - 5.377
Times of eradication treatment, < 2 times-1.3040.36712.590< 0.0010.2710.132 - 0.558
Living in city-0.8170.3664.9950.0250.4420.216 - 0.904
High economic income-1.0270.3667.8560.0050.3580.175 - 0.734
Non-separate meals1.4470.38913.819< 0.0014.2521.982 - 9.121
Lower education degree of the mother1.6140.39217.001< 0.0015.0252.333 - 10.823

5. Discussion

H. pylori infection is among the most common infections in humans, typically occurring during childhood. Although most infected individuals are asymptomatic, about 30% may develop mild to severe upper gastrointestinal diseases (9). With a growing understanding of H. pylori, considerable research has focused on its diagnosis and treatment. In recent decades, there has also been an increasing focus on studying the recurrence of H. pylori infection after eradication, especially in children, where relatively fewer studies have been conducted on the risk factors for recurrence after eradication. This study was performed to comprehensively discuss the risk factors of recurrence of H. pylori infection in children in the local region.

It is acknowledged that the recurrence rate of H. pylori infection is highest in the first year post-eradication and is significantly influenced by socioeconomic conditions (10). Recurrence rates may vary significantly between different countries or even within different regions of the same country. Our study found that the recurrence rate of H. pylori infection in children aged 4 - 16 in the region was 18.6% after one year of follow-up. Literature suggests that recurrence rates in developing countries are much higher than those in developed countries (11, 12). For example, the annual recurrence rate in Latin America is 11.2% (13), while it is 9.3% in Mexico (14). A study in South Korea reported a recurrence rate of 10.9% following eradication (15), and in Vietnam, the reinfection rate was 23.5% after 11 months of follow-up (16). Our study's recurrence rate falls within these reported ranges, indicating significant regional differences in the recurrence of H. pylori infection. The annual reinfection rate among 5,193 H. pylori-infected patients across 15 provinces in China after 6-84 months of follow-up is 1.5% (17), while the rate reported in Chongqing, China, is 4.75% (18). Our study has higher annual recurrence rates than those reported in China and Chongqing, which may be related to the underdeveloped local economy and the demographics of the children involved in this study. Age is another influencing factor for the recurrence of H. pylori infection, with a higher recurrence rate observed in children (19). Research indicates that the one-year recurrence rate of H. pylori infection in children under 10 years old is 20%, while it is 8% in children over 10 years old (20). Our research confirms that being under 10 years old is an independent risk factor for H. pylori infection recurrence, aligning with previous studies (21, 22).

The recurrence of H. pylori infection is a multifactorial process potentially related to personal medical history, family history, health status, and family socioeconomic status. Research has demonstrated that age and socioeconomic status are independently associated with the recurrence of H. pylori infection (23). Additionally, risk factors for the recurrence of H. pylori infection include low education levels, living in rural areas, family members not receiving simultaneous H. pylori eradication treatment, contact with H. pylori-infected patients, and low household income (15, 17, 24-26). Our research findings suggest that living in rural areas, having low economic income, not sharing meals, and having a low maternal education level are independent risk factors for the recurrence of H. pylori infection, consistent with previous reports. Particularly, families with low education levels, rural residence, and low incomes often lack sufficient health knowledge, pay less attention to children's illnesses, and maintain relatively poor hygiene standards. Most of these families share tableware during meals, which are major contributors to the recurrence of H. pylori infection (27, 28).

Given our findings, it can be concluded that younger children may exhibit a higher recurrence rate of H. pylori infection. For children under 10 years old with H. pylori infection, the high risk of recurrence should be considered before starting eradication treatment. Additionally, patients with multiple eradication attempts may face a higher likelihood of recurrence. Therefore, it is essential to adopt regular and systematic treatment strategies to minimize the need for repeated eradication and thus reduce the recurrence rate of H. pylori infection. Promoting good dietary and health habits, as well as reducing the frequency of dining out, can also decrease the recurrence rate of H. pylori infection. This underscores the importance of actively educating the public about H. pylori prevention and control, encouraging meal sharing, and enhancing awareness of H. pylori and health prevention to reduce the recurrence of H. pylori infection.

It should be noted that this study has limitations, including being a single-center study with a small sample size, potential recall bias in the questionnaire survey, and the lack of strain culture and identification. Further research with a larger sample size is planned in an expanded study area to determine whether the recurrence of H. pylori infection is due to the recurrence of the original strain or reinfection by a new strain.

5.1. Conclusions

From January 2020 to June 2021, the recurrence rate of H. pylori infection in children aged 4 - 16 in the Baoding area was relatively high. The combined effect of multiple factors can lead to the recurrence of H. pylori infection in children. The protective factors against the recurrence of Hp infection in children include fewer than two eradication treatments, living in cities, and higher family income. Being younger than 10 years old, not sharing meals, and low maternal education level are independent risk factors for the recurrence of H. pylori infection in children.

References

  • 1.

    Hathroubi S, Servetas SL, Windham I, Merrell DS, Ottemann KM. Helicobacter pylori Biofilm Formation and Its Potential Role in Pathogenesis. Microbiol Mol Biol Rev. 2018;82(2). [PubMed ID: 29743338]. [PubMed Central ID: PMC5968456]. https://doi.org/10.1128/MMBR.00001-18.

  • 2.

    George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front Microbiol. 2020;11:90. [PubMed ID: 32117120]. [PubMed Central ID: PMC7029740]. https://doi.org/10.3389/fmicb.2020.00090.

  • 3.

    Okuda M, Lin Y, Kikuchi S. Helicobacter pylori Infection in Children and Adolescents. Adv Exp Med Biol. 2019;1149:107-20. [PubMed ID: 31037557]. https://doi.org/10.1007/5584_2019_361.

  • 4.

    Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291(2):187-94. [PubMed ID: 14722144]. https://doi.org/10.1001/jama.291.2.187.

  • 5.

    Dohil R, Hassall E. Peptic ulcer disease in children. Baillieres Best Pract Res Clin Gastroenterol. 2000;14(1):53-73. [PubMed ID: 10749089]. https://doi.org/10.1053/bega.1999.0059.

  • 6.

    Ang TL, Ang D. Helicobacter pylori Treatment Strategies in Singapore. Gut Liver. 2021;15(1):13-8. [PubMed ID: 31875670]. [PubMed Central ID: PMC7817935]. https://doi.org/10.5009/gnl19308.

  • 7.

    Yalcin M, Yalcin A, Bengi G, Nak SG. Helicobacter pylori Infection among Patients with Dyspepsia and Intrafamilial Transmission. Euroasian J Hepatogastroenterol. 2016;6(2):93-6. [PubMed ID: 29201737]. [PubMed Central ID: PMC5578573]. https://doi.org/10.5005/jp-journals-10018-1177.

  • 8.

    Wang YK, Kuo FC, Liu CJ, Wu MC, Shih HY, Wang SS, et al. Diagnosis of Helicobacter pylori infection: Current options and developments. World J Gastroenterol. 2015;21(40):11221-35. [PubMed ID: 26523098]. [PubMed Central ID: PMC4616200]. https://doi.org/10.3748/wjg.v21.i40.11221.

  • 9.

    Stefano K, Marco M, Federica G, Laura B, Barbara B, Gioacchino L, et al. Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Bio Medica: Atenei Parmensis. 2018;89(Suppl 8):72.

  • 10.

    Gisbert JP, Luna M, Gomez B, Herrerias JM, Mones J, Castro-Fernandez M, et al. Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients. Aliment Pharmacol Ther. 2006;23(6):713-9. [PubMed ID: 16556172]. https://doi.org/10.1111/j.1365-2036.2006.02827.x.

  • 11.

    Pellicano R, Ribaldone DG, Fagoonee S, Astegiano M, Saracco GM, Mégraud F. A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Panminerva Med. 2016;58(4):304-17. [PubMed ID: 27716738].

  • 12.

    Sun Y, Zhang J. Helicobacter pylori recrudescence and its influencing factors. J Cell Mol Med. 2019;23(12):7919-25. [PubMed ID: 31536675]. [PubMed Central ID: PMC6850920]. https://doi.org/10.1111/jcmm.14682.

  • 13.

    Corral JE, Mera R, Dye CW, Morgan DR. Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention. World J Gastrointest Oncol. 2017;9(4):184-93. [PubMed ID: 28451066]. [PubMed Central ID: PMC5390304]. https://doi.org/10.4251/wjgo.v9.i4.184.

  • 14.

    Sanchez Cuen JA, Irineo Cabrales AB, Leon Sicairos NM, Calderon Zamora L, Monroy Higuera L, Canizalez Roman VA. Recurrence of infection and diversity of Helicobacter pylori strains in an adult population in Mexico treated with empirical standard triple therapy. Rev Esp Enferm Dig. 2017;109(11):749-56. [PubMed ID: 29072083]. https://doi.org/10.17235/reed.2017.4994/2017.

  • 15.

    Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Lee SH, et al. Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea. Helicobacter. 2013;18(2):135-42. [PubMed ID: 23066652]. https://doi.org/10.1111/hel.12018.

  • 16.

    Wheeldon TU, Hoang TT, Phung DC, Bjorkman A, Granstrom M, Sorberg M. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Aliment Pharmacol Ther. 2005;21(8):1047-53. [PubMed ID: 15813841]. https://doi.org/10.1111/j.1365-2036.2005.02408.x.

  • 17.

    Xie Y, Song C, Cheng H, Xu C, Zhang Z, Wang J, et al. Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study. Emerg Microbes Infect. 2020;9(1):548-57. [PubMed ID: 32160805]. [PubMed Central ID: PMC7144303]. https://doi.org/10.1080/22221751.2020.1737579.

  • 18.

    Zhou G. Helicobacter pylori Recurrence after Eradication Therapy in Jiangjin District, Chongqing, China. Gastroenterol Res Pract. 2020;2020:7510872. [PubMed ID: 32328098]. [PubMed Central ID: PMC7165334]. https://doi.org/10.1155/2020/7510872.

  • 19.

    Najafi M, Sobhani M, Khodadad A, Farahmand F, Motamed F. Reinfection rate after successful Helicobacter pylori eradication in children. Iran J Pediatr. 2010;20(1):58.

  • 20.

    Sivapalasingam S, Rajasingham A, Macy JT, Friedman CR, Hoekstra RM, Ayers T, et al. Recurrence of Helicobacter pylori infection in Bolivian children and adults after a population-based "screen and treat" strategy. Helicobacter. 2014;19(5):343-8. [PubMed ID: 24830916]. https://doi.org/10.1111/hel.12137.

  • 21.

    Polivanova TV, Malaty H, Vshivkov VA. Epidemiology Helicobacter pylori infection in children in the Tyva Republic (Russia). Helicobacter. 2022;27(3). e12882. [PubMed ID: 35285106]. https://doi.org/10.1111/hel.12882.

  • 22.

    Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, et al. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(3):185-94. [PubMed ID: 35085494]. https://doi.org/10.1016/S2352-4642(21)00400-4.

  • 23.

    Candelli M, Rigante D, Schiavino A, Gabrielli M, Crea F, Del Lungo LM, et al. High reinfection rate of Helicobacter pylori in young type 1 diabetic patients: a three-year follow-up study. Eur Rev Med Pharmacol Sci. 2012;16(11):1468-72. [PubMed ID: 23111958].

  • 24.

    Xue Y, Zhou LY, Lu HP, Liu JZ. Recurrence of Helicobacter pylori infection: incidence and influential factors. Chin Med J (Engl). 2019;132(7):765-71. [PubMed ID: 30897591]. [PubMed Central ID: PMC6595863]. https://doi.org/10.1097/CM9.0000000000000146.

  • 25.

    Bruce MG, Bruden DL, Morris JM, Reasonover AL, Sacco F, Hurlburt D, et al. Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska. Epidemiol Infect. 2015;143(6):1236-46. [PubMed ID: 25068917]. [PubMed Central ID: PMC9507161]. https://doi.org/10.1017/S0950268814001770.

  • 26.

    Sari YS, Can D, Tunali V, Sahin O, Koc O, Bender O. H pylori: Treatment for the patient only or the whole family? World J Gastroenterol. 2008;14(8):1244-7. [PubMed ID: 18300351]. [PubMed Central ID: PMC2690673]. https://doi.org/10.3748/wjg.14.1244.

  • 27.

    Che TH, Nguyen TC, Vu VNT, Nguyen HT, Hoang DTP, Ngo XM, et al. Factors Associated With Helicobacter Pylori Infection Among School-Aged Children From a High Prevalence Area in Vietnam. Int J Public Health. 2023;68:1605908. [PubMed ID: 37251301]. [PubMed Central ID: PMC10209423]. https://doi.org/10.3389/ijph.2023.1605908.

  • 28.

    Hu J, Wang X, Chua EG, He Y, Shu Q, Zeng L, et al. Prevalence and risk factors of Helicobacter pylori infection among children in Kuichong Subdistrict of Shenzhen City, China. PeerJ. 2020;8. e8878. [PubMed ID: 32280567]. [PubMed Central ID: PMC7134012]. https://doi.org/10.7717/peerj.8878.